Cita APA

Coleman, R. L., Moon, J., Sood, A. K., Hu, W., Delmore, J. E., Bonebrake, A. J., . . . Markman, M. (2014). Randomized Phase II Study of Docetaxel Plus Vandetanib vs. Docetaxel Followed by Vandetanib in Patients with Persistent or Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma: SWOG S0904.

Citación estilo Chicago

Coleman, Robert L., James Moon, Anil K. Sood, Wei Hu, James E. Delmore, Albert J. Bonebrake, Garnet L. Anderson, Setsuko K. Chambers, and Maurie Markman. Randomized Phase II Study of Docetaxel Plus Vandetanib Vs. Docetaxel Followed By Vandetanib in Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma: SWOG S0904. 2014.

Cita MLA

Coleman, Robert L., et al. Randomized Phase II Study of Docetaxel Plus Vandetanib Vs. Docetaxel Followed By Vandetanib in Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma: SWOG S0904. 2014.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.